Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Background: Inflammatory bowel disease (IBD) is commonly treated with immunomodulators such as azathioprine and 6-mercaptopurine (6-MP). Studies examining lymphoma risk in IBD patients treated with these medications have been underpowered and have yielded conflicting conclusions. Aims: The purpose o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Kandiel, A, Fraser, A G, Korelitz, B I, Brensinger, C, Lewis, J D
Natura: Artigo
Lingua:Inglês
Pubblicazione: Copyright 2005 by Gut 2005
Soggetti:
Inflammatory Bowel Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774897/
https://ncbi.nlm.nih.gov/pubmed/16009685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.049460
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi